Advanced

Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

Calara, Paul S; Norlin, Jenny M; Althin, Rikard; Steen Carlsson, Katarina LU and Schmitt-Egenolf, Marcus (2016) In BioDrugs
Abstract
Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
BioDrugs
publisher
Adis International
external identifiers
  • pmid:26883786
  • scopus:84958745150
  • wos:000376501000008
ISSN
1173-8804
DOI
10.1007/s40259-016-0163-8
language
English
LU publication?
yes
id
821b3f88-f5d4-481c-adda-f23967279b6e (old id 8825270)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26883786?dopt=Abstract
date added to LUP
2016-03-03 11:00:13
date last changed
2017-02-05 04:38:05
@article{821b3f88-f5d4-481c-adda-f23967279b6e,
  abstract     = {Previous research indicates an uneven uptake of biologics in patients with moderate-to-severe psoriasis in Sweden. Therefore, it is essential to scrutinise variations in treatment patterns.},
  author       = {Calara, Paul S and Norlin, Jenny M and Althin, Rikard and Steen Carlsson, Katarina and Schmitt-Egenolf, Marcus},
  issn         = {1173-8804},
  language     = {eng},
  month        = {02},
  publisher    = {Adis International},
  series       = {BioDrugs},
  title        = {Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.},
  url          = {http://dx.doi.org/10.1007/s40259-016-0163-8},
  year         = {2016},
}